Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Larsson

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Fertility and Sterility|February 1, 1981
Lipoprotein changes may be minimized by proper composition of a combined oral contraceptiveU Larsson-Cohn, L Fåhraeus, L Wallentin, et al.
Maturitas|January 1, 1980
Effects of postmenopausal ethinylestradiol treatment on gallbladder bileR Heuman, U Larsson-Cohn, M Hammar, et al.
The Journal of Obstetrics and Gynaecology of the British Commonwealth|September 1, 1970
Effects of daily administration of a retrosteroid on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogensU Larsson-Cohn, E D Johansson, L Wide, et al.
British Journal of Obstetrics and Gynaecology|May 1, 1978
Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapyU Larsson-Cohn, E D Johansson, B Kågedal, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1986
Effects on the lipoprotein metabolism of an antiandrogen-estrogen oral contraceptive drugU Larsson-Cohn, L Fåhraeus, H von Schenck, et al.
Acta Medica Scandinavica|October 1, 1971
Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activityS Rössner, U Larsson-Cohn, L A Carlson, et al.
Acta Paediatrica Scandinavica|March 1, 1978
Subclinical protein-energy malnutrition in under-privileged Ethiopian mothers and their newborn infantsM Gebre-Medhin, U Larsson, B S Lindblad, et al.
Acta Endocrinologica|April 1, 1970
Effects of continuous daily administration of 0.5 mg of chlormadinone acetate on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogensU Larsson-Cohn, E D Johansson, L Wide, et al.
Acta Endocrinologica|November 1, 1972
Effects of continuous daily administration of 0.1 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogensU Larsson-Cohn, E D Johansson, L Wide, et al.
Acta Endocrinologica|February 1, 1970
Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogensU Larsson-Cohn, E D Johansson, L Wide, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Fertility and Sterility|February 1, 1981
Lipoprotein changes may be minimized by proper composition of a combined oral contraceptiveU Larsson-Cohn, L Fåhraeus, L Wallentin, et al.
Maturitas|January 1, 1980
Effects of postmenopausal ethinylestradiol treatment on gallbladder bileR Heuman, U Larsson-Cohn, M Hammar, et al.
The Journal of Obstetrics and Gynaecology of the British Commonwealth|September 1, 1970
Effects of daily administration of a retrosteroid on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogensU Larsson-Cohn, E D Johansson, L Wide, et al.
British Journal of Obstetrics and Gynaecology|May 1, 1978
Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapyU Larsson-Cohn, E D Johansson, B Kågedal, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1986
Effects on the lipoprotein metabolism of an antiandrogen-estrogen oral contraceptive drugU Larsson-Cohn, L Fåhraeus, H von Schenck, et al.
Acta Medica Scandinavica|October 1, 1971
Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activityS Rössner, U Larsson-Cohn, L A Carlson, et al.
Acta Paediatrica Scandinavica|March 1, 1978
Subclinical protein-energy malnutrition in under-privileged Ethiopian mothers and their newborn infantsM Gebre-Medhin, U Larsson, B S Lindblad, et al.
Acta Endocrinologica|April 1, 1970
Effects of continuous daily administration of 0.5 mg of chlormadinone acetate on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogensU Larsson-Cohn, E D Johansson, L Wide, et al.
Acta Endocrinologica|November 1, 1972
Effects of continuous daily administration of 0.1 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogensU Larsson-Cohn, E D Johansson, L Wide, et al.
Acta Endocrinologica|February 1, 1970
Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogensU Larsson-Cohn, E D Johansson, L Wide, et al.
Pageof 10